2.03
-0.115(-5.36%)
Currency In USD
| Previous Close | 2.15 |
| Open | 2.12 |
| Day High | 2.2 |
| Day Low | 2.02 |
| 52-Week High | 11.66 |
| 52-Week Low | 1.87 |
| Volume | 93,976 |
| Average Volume | 696,474 |
| Market Cap | 7.04M |
| PE | -0.17 |
| EPS | -12.05 |
| Moving Average 50 Days | 2.61 |
| Moving Average 200 Days | 3.7 |
| Change | -0.12 |
If you invested $1000 in Avalon GloboCare Corp. (ALBT) since IPO date, it would be worth $6.01 as of August 20, 2025 at a share price of $2.03. Whereas If you bought $1000 worth of Avalon GloboCare Corp. (ALBT) shares 5 years ago, it would be worth $7.87 as of August 20, 2025 at a share price of $2.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders
GlobeNewswire Inc.
Jul 28, 2025 1:00 PM GMT
FREEHOLD, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that its subsidiary, Q&A Distribution, LLC, has entered into
Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong
GlobeNewswire Inc.
Jul 14, 2025 12:00 PM GMT
FREEHOLD, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced the issuance of a new standard patent by the Hong Kong Intel
Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving
GlobeNewswire Inc.
Jun 26, 2025 12:00 PM GMT
FREEHOLD, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that it entered into a definitive agreement with Qi Diagnost